Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 1999

View Archived Issues

MCH binding receptor identified

Ontogen completes phase I bioavailability study of MDR-modulating compound

Hemosol's Hemolink clinical trial program progresses as planned

PMA for Cygnus's glucose monitor receives expedited review status

Integra LifeSciences's dural graft matrix granted 510(k) clearance by FDA

NeoPath and Bayer Diagnostics collaborate on lung cancer screening test

SB and Finlay Institute of Cuba enter agreement for bacterial meningitis vaccine

Study examines capability of antidementia drug candidate FK-960 to restore rCBF response

Further evidence of the efficacy of JE-2147, an improved HIV protease inhibitor

Neurocrine Biosciences initiates phase II studies for insomnia treatment

PA153, a novel agent for the diagnosis and treatment of pancreatic diseases

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Kirin Brewery patents quinoline derivatives with broad potential therapeutic application

Novel MTP inhibitors in early development at Japan Tobacco

DuPont introduces NNRTI in first major European market

Aeolus receives notice of allowance for U.S. patent covering synthetic SOD mimetics

GelTex seeks FDA approval of Cholestagel

Bristol-Myers Squibb describes lobucavir prodrugs with improved oral bioavailability

Zeffix approved in E.U. for chronic HBV

Alcon describes therapeutic potential of ocular antiinflammatory agents

Gilead completes acquisition of NeXstar

Allergan profiles its Ocular Hypotensive Lipids at SOE 1999

Genentech seeks FDA approval for tenecteplase

Travoprost is safe and effective in treating elevated IOP in glaucoma patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...